Connect with us

Hi, what are you looking for?

Stock

Unlock the Power of StockCharts’ NEW Market Summary Dashboard | Walkthrough & Tips

In this in-depth walkthrough, Grayson introduces the brand-new Market Summary Dashboard, an all-in-one resource designed to help you analyze the market with ease, speed,...

2 hours ago

Popular News

Stock

The S&P 500 Snapped Back Hard: Now What?

The S&P 500 ($SPX) just staged one of the sharpest rebounds we’ve seen in years. After tumbling into deeply oversold territory earlier this year,...

2 hours ago

Stock

SMCI Stock Rebounds: Why Its SCTR Score is Screaming for Attention

Let’s be real. How many of you kicked yourselves for not jumping into some long positions last Friday? Of course, hindsight is 20/20, and...

2 hours ago

Latest News

Russia and Ukraine are due to meet – but who’ll show up? Here’s what we know

Ukraine’s President Volodymyr Zelensky might meet Russia’s President Vladimir Putin in Turkey on Thursday – if the Russian leader decides to show up for...

2 hours ago

Investing

Investing

High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation

Errawarra Resources Ltd (ASX: ERW) is pleased to advise that recent surface sampling at its Elizabeth Hill Project has returned multiple elevated portable XRF...

2 hours ago

Investing

Multiple Uranium Anomalies Identified at Key NT Projects

Greenvale Energy (GRV:AU) has announced Multiple Uranium Anomalies Identified at Key NT Projects Download the PDF here. This post appeared first on investingnews.com

2 hours ago

Investing

Eric Nuttall: Oil vs. Natural Gas Stocks, Plus 2025 Prices, Supply and Demand

Eric Nuttall, partner and senior portfolio manager at Ninepoint Partners, shares his outlook for oil and natural gas, honing in on supply, demand and...

2 hours ago

Investing

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce important new data from our ongoing ACCENT clinical trial in pancreatic...

2 hours ago

Stock

My Downside Target for the S&P 500

Things heated up this week on , featuring interviews with Kristina Hooper of Invesco, Keith Fitz-Gerald of The Fitz-Gerald Group, and Jordan Kimmel of...

March 8, 2025
More Posts
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Dealwithbiz.com